Results 101 to 110 of about 1,796 (202)

CLTC-ALK Fusion as a Primary Event in Congenital Blastic Plasmacytoid Dendritic Cell Neoplasm [PDF]

, 2014
Ehime University (愛媛大学)博士(医学 ...
TOKUDA, Kiriko, 徳田, 桐子
core  

Blastic Plasmacytoid Dendritic Cell Neoplasm, from a Dermatological Point of View [PDF]

blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive hematological malignancy derived from the precursors of plasmacytoid dendritic cells.
Bianchi L., Campione E., Di Domenico P. P., Di Raimondo C., Galluzzo M., Lozzi F., Paganini C.   +6 more
core   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm with Extensive Cutaneous and Central Nervous System Involvement [PDF]

, 2014
Blastic plasmacytoid dendritic neoplasm is an exceedingly rare tumor that has undergone several changes in nomenclature over the last two decades, largely because of confusion regarding its cell of origin.
Al-Qaisi, Abeer, Awasthi, Mukta, Massarweh, Suleiman, Saeed, Hayder   +3 more
core   +3 more sources

Bruise-like cutaneous lesions as the early presentation of blastic plasmacytoid dendritic cell neoplasm

Dermatologica Sinica, 2014
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a very rare and highly aggressive hematopoietic malignancy associated with a poor prognosis. It has been recognized to originate from precursors of plasmacytoid dendritic cells and has recently been
Yi-Hsuan Chou, Ruey-Yi Lin, Meng-Sui Lee, Hsiao-Ping Wu, Che-Pin Lin, Chen-Yi Wu   +5 more
doaj   +1 more source

Immune-Based Therapeutic Strategies for Acute Myeloid Leukemia [PDF]

, 2023
The development and design of immune-based strategies have become an increasingly important topic during the last few years in acute myeloid leukemia (AML), based on successful immunotherapies in solid cancer.
Böhme, Matthias, Kayser, Sabine
core   +1 more source

Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects

Blood and Lymphatic Cancer: Targets and Therapy, 2017
Amy M Trottier, Sonia Cerquozzi, Carolyn J Owen Division of Hematology and Hematological Malignancies, University of Calgary, Foothills Medical Centre, Calgary, AB, Canada Abstract: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare CD4+ CD56+
Trottier AM, Cerquozzi S, Owen CJ
doaj  

Therapeutic Approaches for Blastic Plasmacytoid Dendritic Cell Neoplasm: Allogeneic Hematopoietic Cell Transplantation and Novel Therapies

Clinical Hematology International, 2019
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a clinically aggressive hematologic malignancy derived from precursors of plasmacytoid dendritic cells.
Mohamed A. Kharfan-Dabaja, Naveen Pemmaraju, Mohamad Mohty   +2 more
doaj   +1 more source

A new palliative treatment for blastic plasmacytoid dendritic cell neoplasm: a case report and review of the literature

Journal of International Medical Research, 2019
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare haematological malignancy that derives from plasmacytoid dendritic cells. The cancer is characterized by aggressive development and dismal prognosis, and due to limited prospective study ...
Yunning Yang, Yuanyuan Xu, You Nie, Hongwei Wang, Shan Long, Xiaosong Li   +5 more
doaj   +1 more source

Challenges and practical considerations in the management of blastic plasmacytoid dendritic cell neoplasm: A single-center experience

Leukemia Research Reports
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is a rare and often life-threatening complex hematologic malignancy that can commonly infiltrate the skin, lymph nodes, central nervous system, and bone marrow.
Haripriya Andanamala, Naveen Pemmaraju, Taha Al-Juhaishi   +2 more
doaj   +1 more source

OncoLog, Volume 63, Number 02, February 2018 [PDF]

, 2018
Radiation Therapy for Liver Cancer: Clinical trials expand treatment options for patients with primary liver cancer Proton Therapy for Breast Cancer May Avoid Heart Damage: Trial compares cardiotoxicity of proton-and photon-based radiation therapy to the
Bronson, Sarah, Tutt, Bryan
core